Business Context and Reporting Period
This Form 8-K Current Report was filed by SkinHealth Systems Inc. (formerly The Beauty Health Company) on April 22, 2026, covering events occurring on April 17, 2026, and April 22, 2026. The filing primarily addresses corporate governance changes, including the appointment of new directors and a formal change to the company's legal name.
Key Financial Metrics
This filing does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity metrics within this document.
Material Changes
- Corporate Name Change: The company officially changed its name from "The Beauty Health Company" to "SkinHealth Systems Inc." effective April 22, 2026, following the filing of a third certificate of amendment with the Delaware Secretary of State.
- Board Expansion and Appointments: The Board of Directors increased its size from nine to eleven members. Three new independent directors were appointed effective April 17, 2026:
- Kenneth Tripp: Senior Vice President of Global Operations and Logistics at Zimmer Biomet Holdings, Inc., appointed to the Audit Committee.
- Dr. Sachin Shridharani: Board-certified plastic surgeon and founder of LUXURGERY, appointed to the Nominating and Corporate Governance Committee.
- E. Scott Beattie: Former CEO of Elizabeth Arden, Inc. and seasoned consumer-products executive, appointed to the Compensation Committee.
- Board Composition Outlook: The Board decided not to nominate current directors Ms. Desiree Gruber and Dr. Philippe Schaison for reelection at the 2026 Annual Meeting. Upon the conclusion of that meeting, the Board size is expected to return to nine directors.
- Bylaw Amendments: The company amended and restated its bylaws to reflect the name change and update governance procedures, including clarifications on stockholder lists, director terms for vacancies, and the Chairman's duties.
Guidance, Outlook, and Risks
The filing includes press releases (Exhibits 99.1 and 99.2) containing forward-looking statements. Management notes that these statements involve risks, uncertainties, and assumptions that may cause actual results to differ materially from expectations. No specific financial guidance or operational outlook was provided in the text of this report.
Investor Verification Checklist
- Verify the ticker symbol and trading status of "SkinHealth Systems Inc." (SKIN) on the Nasdaq Capital Market following the name change.
- Review the company's Proxy Statement on Schedule 14A (filed April 25, 2025) for details on the standard compensatory arrangements for the newly appointed directors.
- Confirm the specific dates and procedures for the 2026 Annual Meeting of stockholders where the Board size is expected to be reduced.
- Examine the Restated Certificate of Incorporation and Second Amended and Restated Bylaws (Exhibits 3.2 and 3.3) for full details on governance updates.